Moore PS - Search Results

1

Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL.

Moore PS, Missiaglia E, Antonello D, Zamò A, Zamboni G, Corleto V, Falconi M, Scarpa A. Moore PS, et al. Genes Chromosomes Cancer. 2001 Oct;32(2):177-81. doi: 10.1002/gcc.1180. Genes Chromosomes Cancer. 2001. PMID: 11550286

2

Sex chromosome anomalies in pancreatic endocrine tumors.

Missiaglia E, Moore PS, Williamson J, Lemoine NR, Falconi M, Zamboni G, Scarpa A. Missiaglia E, et al. Among authors: moore ps. Int J Cancer. 2002 Apr 1;98(4):532-8. doi: 10.1002/ijc.10223. Int J Cancer. 2002. PMID: 11920612

3

Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer.

Antonello D, Moore PS, Zamboni G, Falconi M, Scarpa A. Antonello D, et al. Among authors: moore ps. Cancer Lett. 2002 Sep 26;183(2):179-83. doi: 10.1016/s0304-3835(01)00802-3. Cancer Lett. 2002. PMID: 12065093

4

Genetic abnormalities in pancreatic cancer.

Moore PS, Beghelli S, Zamboni G, Scarpa A. Moore PS, et al. Mol Cancer. 2003 Jan 7;2:7. doi: 10.1186/1476-4598-2-7. Mol Cancer. 2003. PMID: 12537585 Free PMC article. Review.

5

Molecular characterization of pancreatic serous microcystic adenomas: evidence for a tumor suppressor gene on chromosome 10q.

Moore PS, Zamboni G, Brighenti A, Lissandrini D, Antonello D, Capelli P, Rigaud G, Falconi M, Scarpa A. Moore PS, et al. Am J Pathol. 2001 Jan;158(1):317-21. doi: 10.1016/S0002-9440(10)63971-5. Am J Pathol. 2001. PMID: 11141506 Free PMC article.

6

Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.

Moore PS, Orlandini S, Zamboni G, Capelli P, Rigaud G, Falconi M, Bassi C, Lemoine NR, Scarpa A. Moore PS, et al. Br J Cancer. 2001 Jan;84(2):253-62. doi: 10.1054/bjoc.2000.1567. Br J Cancer. 2001. PMID: 11161385 Free PMC article.

7

High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications.

Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D, Rindi G, Grigolato P, Pederzoli P, Scarpa A. Rigaud G, et al. Among authors: moore ps. Cancer Res. 2001 Jan 1;61(1):285-92. Cancer Res. 2001. PMID: 11196176

8

Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms.

Gumbs AA, Moore PS, Falconi M, Bassi C, Beghelli S, Modlin I, Scarpa A. Gumbs AA, et al. Among authors: moore ps. J Surg Oncol. 2002 Sep;81(1):45-53; discussion 54. doi: 10.1002/jso.10142. J Surg Oncol. 2002. PMID: 12210027 Review.

9

Dpc4 is expressed in virtually all primary and metastatic pancreatic endocrine carcinomas.

Scarpa A, Orlandini S, Moore PS, Lemoine NR, Beghelli S, Baron A, Falconi M, Zamboni G. Scarpa A, et al. Among authors: moore ps. Virchows Arch. 2002 Feb;440(2):155-159. doi: 10.1007/s00428-001-0569-6. Virchows Arch. 2002. PMID: 11964045

10

Overexpression of the Sm-like proto-oncogene in primary and metastatic pancreatic endocrine tumors.

Gumbs AA, Bassi C, Moore PS, Falconi M, Frigerio I, Baron A, Piemonti L, Modlin I, Scarpa A. Gumbs AA, et al. Among authors: moore ps. JOP. 2002 Jul;3(4):109-15. JOP. 2002. PMID: 12110768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters